References

American Hospital Formulary Service Drug Information.Bethesda (MD)2004

Amer M, Metwalli M. Topical hydroquinone in the treatment of some hyperpigmentary disorders. Int J Dermatol.. 1998; 37:(6)449-450 https://doi.org/10.1046/j.1365-4362.1998.00499.x

Bandyopadhyay D. Topical treatment of melasma. Indian J Dermatol.. 2009; 54:(4)303-309 https://doi.org/10.4103/2F0019-5154.57602

Gupta AK, Gover MD, Nouri KD, Taylor S. The treatment of melasma: a review of clinical trials. J Am Acad Dermatol.. 2006; 55:(6)1048-1065 https://doi.org/10.1016/j.jaad.2006.02.009

Halder RN, Grimes PE, McLaurin CI, Kress MA, Kennery JA. Incidence of common dermatoses in a predominantly black dermatologic practice. Cutis.. 1983; 32:(4)388-390

Halder R, Nordlund JJ. Topical treatment of pigmentary disorders. In: Nordlund JJ, Boissy RE, Hearing VJ, King RA, Ortonne JP (eds). New York (NY): Oxford University Press; 1998

Herndon JH, Stephens TJ, Sigler ML. Efficacy of a tretinoin/hydroquinone-based skin health system in the treatment of facial photodamage. Cosmetic Derm.. 2006; 19:(4)255-262

Kimbrough-Green CK, Griffiths CE, Finkel LJ Topical retinoic acid for melasma in black patients: a vehicle-controlled clinical trial. Arch Dermatol.. 1994; 130:727-733

Kligman AM, Willis I. A new formula for depigmenting human skin. Arch Dermatol.. 1975; 111:(1)40-48

Marks R. Photoprotection and prevention of melanoma. Eur J Dermatol.. 1999; 9:(5)406-412

Majid I, Haq I, Imran S, Keen A, Aziz K, Arif T. Proposing Melasma Severity Index: a new, more practical, office-based scoring system for assessing the severity of melasma. Indian J Dermatol.. 2016; 61:(1)39-44 https://doi.org/10.4103/0019-5154.174024

Physicians' desk reference, 57th edn. In: Murray L (ed). Montvale (NJ): Thomson PDR; 2003

The pigmentary system: physiology and pathophysiology. In: Nordlund JJ, Boissy RE, Hearing VJ, King RA, Ortonne JP (eds). New York (NY): Oxford University Press; 1998

Ortonne JP, Arellano I, Berneburg M A global survey of the role of ultraviolet radiation and hormonal influences in the development of melasma. J Eur Acad Dermatol Venereol.. 2009; 23:(11)1254-1262 https://doi.org/10.1111/j.1468-3083.2009.03295.x

Palumbo A, d'Ischia M, Misuraca G, Prota G. Mechanism of inhibition of melanogenesis by hydroquinone. Biochim Biophys Acta.. 1991; 1073:(1)85-90 https://doi.org/10.1016/0304-4165(91)90186-k

Pandya AG, Hynan LS, Bhore R Reliability assessment and validation of the Melasma Area and Severity Index (MASI) and a new modified MASI scoring method. J Am Acad Dermatol.. 2011; 64:(1)78-83 https://doi.org/10.1016/j.jaad.2009.10.051

Pannucci CJ, Reavey PL, Kaweski S A randomized controlled trial of skin care protocols for facial resurfacing: lessons learned from the Plastic Surgery Educational Foundation's Skin Products Assessment Research study. Plast Reconstr Surg.. 2011; 127:(3)1334-1342 https://doi.org/10.1097/prs.0b013e318204361d

Pasricha JS, Khaitan BK, Dash S. Pigmentary disorders in India. Dermatol Clin.. 2007; 25:343-352 https://doi.org/10.1016/j.det.2007.05.004

Pathak MA, Riley FC, Fitzpatrick TB. Melanogenesis in human skin following exposure to long-wave ultraviolet and visible light. J Invest Dermatol.. 1962; 39:435-443

Resnik S. Melasma induced by oral contraceptive drugs. JAMA.. 1967; 199:(9)601-605

Rodrigues R, Pandya AG. Melasma: clinical diagnosis and management options. Australas J Dermatol.. 2015; 56:(3)151-163 https://doi.org/10.1111/ajd.12290

Sheth VM, Pandya AG. Melasma: a comprehensive update: part I. J Am Acad Dermatol.. 2011; 65:(4)689-697 https://doi.org/10.1016/j.jaad.2010.12.046

Sodhi VK, Sausker WF. Dermatoses of pregnancy. Am Fam Phys.. 1988; 37:(1)131-138

Urabe K, Nakayama J, Hori Y. Mixed epidermal and dermal hypermelanoses. In: Nordlund JJ, Boissy RE, Hearing VJ, King RA, Ortonne JP (eds). New York (NY): Oxford University Press; 1998

Vazquez M, Maldonado H, Benmaman C, Sanchez JL. Melasma in men: a clinical and histologic study. Int J Dermatol.. 1988; 27:(1)25-27 https://doi.org/10.1111/j.1365-4362.1988.tb02329.x

Dermatology

Facial pigmentation and melasma reduction using a hydroquinone- and tretinoin-based skin transformation system

02 July 2021
Clinical
02 July 2021
Volume 10 · Issue 6

Abstract

Many patients present to clinics with hyperpigmentation and melasma, and a hydroquinone/tretinoin-based skin system can be an effective treatment. The author presents two case studies in this article: one is related to a 50-year-old patient with melasma on her cheeks and the other, to a 40-year-old patient who presented with pigmentation. Both patients had these conditions for many years and had used numerous products in the past with no success. The melasma and pigmentation had a huge impact on their daily life, and, after thorough consultations, they used the Obagi Nu Derm Transformation System® with tretinoin. This article will describe a hydroquinone- and tretinoin-based system and some of the results achieved.

Dr Manav Bawa

Many patients present with facial skin pigmentation in clinics. The impact of pigmentation and melasma can be extremely significant, causing distress and low self-esteem. There are numerous ways to treat skin conditions, including pigmentation and melasma, and one of the first and most important parts of the patient journey is to perform a thorough consultation. This is a way to obtain all relevant information about the patient, the impact that their concerns has on them (including the psychological implications) and the physical signs that are present.

Spending time discussing the patient's concerns and setting realistic expectations is encouraged, as it is important for them to understand the pathology and pathophysiology of their concern. Once understood, most patients will be able to gauge the reasons why certain treatments will be more beneficial than others.

In this article, the author will discuss hyperpigmentation, treatments and the Obagi Nu Derm Transformation System (ONDS), with results from two patients.

Register now to continue reading

Thank you for visiting Journal of Aesthetic Nurses and reading some of our peer-reviewed resources for aesthetic nurses. To read more, please register today. You’ll enjoy the following great benefits:

What's included

  • Limited access to clinical or professional articles

  • New content and clinical newsletter updates each month

Register
Or continue by

Signing in with your registered email address

Melasma
Pigmentation
Medical skincare
Hydroquinone
Tretinoin